The Walden Group is pleased to provide access to its Q2 2023 Strategic Healthcare M&A Report, which includes:
Q2 2023 Market Overview
Noteworthy M&A Deals By Sector
Top Deals > $100m in Transaction Value Announced or Closed in Q2 2023
Performance of Leading Healthcare Companies
Analysis of...
Read More
The Walden Group is pleased to provide access to its Q1 2023 Strategic Healthcare M&A Report, which includes:
Q1 2023 Market Overview
Noteworthy M&A Deals By Sector
Top Deals > $100m in Transaction Value Announced or Closed in Q1 2023
Performance of Leading Healthcare Companies
Analysis...
Read More
Spain-based manufacturer and distributor of diagnostic instruments Werfen has acquired Immucor, a manufacturer of transfusion and transplant diagnostic devices. The acquisition adds platelet detection, diagnostic analyzers, blood monitoring and molecular testing products that help match patients and donors. Deal terms -- $2b.
Keywords:...
Read More
The Walden Group is pleased to provide access to its Q4 2022 Strategic Healthcare M&A Report, which includes:
Recent Divestitures and Spin-Offs
Diagnostic and Medical Device Deals with Valuations over $100m
Noteworthy M&A Deals By Sector
Top Deals > $100m in Transaction Value Announced or Closed in 2022
...
Read More
Shockwave Medical, a $237m developer of technologies treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease, is acquiring Neovasc, a $2.5m Canada-based developer of transcatheter devices treating refractory angina and mitral valve disease. Deal terms – $100m upfront plus $47m in milestones...
Read More